简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Bioceres报告第三季度业绩

2025-05-21 19:06

  • Bioceres press release (NASDAQ:BIOX): Q3 net loss was $1.6 million
  • Revenue of $60.6M (-27.9% Y/Y).
  • Total revenues were $60.6 million in 3Q25, compared to $84.0 million for the same quarter last year, primarily due to an expected $15.7 year-over-year negative difference related to the accrual in 3Q24 of Syngenta’s initial downpayment.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。